10.1002/chem.201700783
Chemistry - A European Journal
FULL PAPER
controlled the receptor subunits being expressed in our
heterologous cells and thus the exact identity of the GABAA
receptors being tested is always known. In this report, we chose
the most abundant subunit combination in the mammalian CNS
(α1β22L) to determine the potency of TETS and its analogues.
In contrast to TETS (IC50 = 7.9 ± 2.6 µM, n = 12), TETS analog
4a, identified as the most active analog in the SCO assays, only
exhibited modest activity (IC50 = 48.0 ± 13.2 µM, n = 10) (Figure
5). Two additional analogs, 2a and 2c, which also showed some
activity in the FLIPR assays, were determined to have
comparable inhibitory effect on GABA-induced currents as 4a at
the 50 µM test concentration (4a 43.9 ± 2.1%, n = 3; 2a 59.8 ±
20.5%, n = 5; 2c 59.4 ± 12.6%, n = 3). None of the tested
analogs were more potent than TETS (69.4±1.0%, n = 4) on our
receptors of choice.
antibodies recognized TETS with sensitivities higher than 5
µg/mL. Use of these sera for the development of the first
immunoassay for sensitive detection and quantification of TETS
will be published in due course.
Acknowledgements
This work was supported by the CounterACT Program, National
Institutes of Health Office of the Director, and the National
Institute of Neurological Disorders and Stroke, Grant Number
U54 NS079202; and NIEHS, Superfund Research Program, P42
ES04699.
Keywords: poly-heterocycles, tetramine, cage convulsants,
Thus, we have successfully synthesized and identified
analogues of TETS that are active on GABAA receptors. Despite
being several fold less potent then TETS in our
electrophysiological studies, these analogues retained the
functional groups required for binding and blocking α1β22L
GABAA receptors. Additionally, although TETS is a known
GABAA receptor inhibitor, its exact binding site and selectivity for
the various GABAA receptor subtypes have not been
investigated. Thus, further testing of these analogues and TETS
on additional GABAA receptor subtypes will provide the
information on their exact potency and selectivity on the GABAA
receptors. The fact that analogues and TETS exhibit a different
potency ranking in the SCO and the patch-clamp experiments is
probably caused by the fundamentally different nature of the two
assays which in one case uses Ca2+ signaling as a downstream
effect of GABAA receptor blockade while directly measuring
blockade of GABA-induced chloride currents in the other.
Another possibility could be that the TETS analogous exhibit
differential selectivity for different GABAA receptor subtypes
present in the hippocampal neurons used for the SCO
experiments.
neurotoxicity, GABA, antibody-based assay.
[1] International
Program
on
Chemical
Safety
[2] E. Croddy, Arch Toxicol 2004, 78, 1-6.
[3] a) J. M. Li, J. Gan, T. F. Zeng, J. W. Sander, D. Zhou,
Neurotoxicology 2012, 33, 207-211; b) Y. Li, Y. X. Gao, X.
Z. Yu, J. M. Peng, F. Ma, L. Nelson, Bmc Public Health
2014, 14.
[4] a) P. Goel, African Journal of Biotechnology 2013, 12,
7158-7167; b) J. Sherry, Chemosphere 1997, 34, 1011-
1025; c) L. Anfossi, C. Baggiani, C. Giovannoli, G. D'Arco,
G. Giraudi, Anal Bioanal Chem 2013, 405, 467-480; d) O.
Kavanagh, C. T. Elliott, K. Campbell, Anal Bioanal Chem
2015, 407, 2749-2770; e) M. Franek, K. Hruska, Vet Med-
Czech 2005, 50, 1-10; f) V. S. Morozova, A. I. Levashova, S.
A. Eremin, J Anal Chem+ 2005, 60, 202-217.
[5] a) N. Vasylieva, K. C. Ahn, B. Barnych, S. J. Gee, B. D.
Hammock, Environmental science & technology 2015, 49,
10038-10047; b) M. Franek, V. Kolar, M. Granatova, Z.
Nevorankova, J Agr Food Chem 1994, 42, 1369-1374; c) J.
Y. Yang, H. Wang, Y. M. Jiang, Y. M. Sun, K. T. Pan, H. T.
Lei, Q. Wu, Y. D. Shen, Z. L. Xiao, Z. L. Xu, Molecules
2008, 13, 871-881; d) J. K. Lee, K. C. Ahn, O. S. Park, S. Y.
Kang, B. D. Hammock, J Agr Food Chem 2001, 49, 2159-
2167.
Conclusions
[6] T. Esser, A. E. Karu, R. F. Toia, J. E. Casida, Chemical
research in toxicology 1991, 4, 162-167.
In summary we have developed a general synthetic approach
toward two classes of tricyclic sulfamides structurally related to
the neurotoxic TETS molecule. Bioactivity of some of the
synthesized compounds was evaluated by studying their effects
on synchronous calcium oscillations in cultured hippocampal
neurons and on receptor currents in cells expressing α1β22L
GABAAR and the results were compared to those of the parent
TETS compound. Although none of the tested TETS analogues
was as potent as TETS, the potency of some was only an order
of magnitude lower on α1β22L GABAAR compared to TETS. In
view of a recent burst of research interest in the sulfamide
pharmacophore for the development of new medicines for a
broad spectrum of pharmacological targets[25] the tricyclic
sulfamides described here appear to be useful building blocks
for the construction of new drug candidates. Six TETS
analogues were used for conjugation to the carrier protein and
rabbit immunization. Preliminary data suggest that the produced
[7] C. Janeway, P. Travers, M. Walport, M. Shlomchik, in
Immunobiology: The Immune System in Health and
Disease, 5th ed., Garland Science, New York, 2001.
[8] a) R. O. Harrison, M. H. Goodrow, S. J. Gee, B. D.
Hammock, Acs Sym Ser 1990, 451, 14-27; b) A. E. Karu, in
Hazard assessment of chemicals, Vol. 8 (Ed.: J. Saxena),
Taylor and Francis, 1984, pp. 232-243; c) P. Tijssen, in
Practice and Theory of Enzyme Immunoassays, Vol. 15
(Eds.: R. H. Burdon, P. H. Knippenberg), Elsevier,
Amsterdam, The Netherlands, 1985.
[9] C. H. Lee, H. Kohn, J Org Chem 1990, 55, 6098-6104.
[10]J. Dusemund, T. Schurreit, Arch Pharm 1986, 319, 826-829.
[11] a) S. D. Mcdermott, W. J. Spillane, Org Prep Proced Int
1984, 16, 49-77; b) K. C. Nicolaou, D. A. Longbottom, S. A.
Snyder, A. Z. Nalbanadian, X. H. Huang, Angew Chem Int
Edit 2002, 41, 3866-3870.
[12] Y. Masui, H. Watanabe, T. Masui, Tetrahedron Lett 2004,
45, 1853-1856.
This article is protected by copyright. All rights reserved.